The US Food and Drug Administration’s Office of Prescription Drug Promotion is honing in on another aspect of Rx drug promotions: presentations about a product’s “targeted mechanism of action.”
OPDP announced the proposed study, “Targeted Mechanism of Action Presentations in Prescription Drug Promotion,” in a Federal Register notice last week
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?